ASRT
Assertio Holdings, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$23.50
+0.00%Latest reported
- Last report date
- May 8, 2026
- EPS actual
- -$2.93
- EPS estimate
- -$1.91
- Revenue actual
- $9.9M
- Revenue estimate
- $9.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +704.2%
- Revenue beats (12Q)
- 6
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 8, 2026 | -$1.91 | -$2.93 | Miss -53.40% | $9.9M |
| Mar 16, 2026 | -$3.12 | -$1.86 | Beat 40.43% | $13.5M |
| Mar 12, 2025 | -$0.05 | -$0.11 | Miss -120.00% | $32.2M |
| Mar 11, 2024 | -$0.00 | $0.11 | Beat 2949.74% | $33.0M |
| Aug 3, 2023 | $0.14 | $0.13 | Miss -7.14% | $41.0M |
| Mar 8, 2023 | $0.23 | $1.34 | Beat 482.61% | $50.4M |
| Mar 9, 2022 | $0.12 | $0.10 | Miss -16.67% | $33.3M |
| Nov 4, 2021 | $0.02 | $0.08 | Beat 300.00% | $25.5M |
| Aug 5, 2021 | -$0.08 | -$0.32 | Miss -300.00% | $25.4M |
| May 6, 2021 | $0.08 | $0.16 | Beat 100.00% | $26.8M |
| Mar 11, 2021 | — | $0.12 | — | $32.0M |
| Nov 6, 2020 | -$0.03 | $0.08 | Beat 399.96% | $34.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jul 30, 2026